Data gathered: October 17
Alternative Data for Henry Schein
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 131 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 678,000 | Sign up | Sign up | Sign up |
| Employee Rating | 80 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 1 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 55 | Sign up | Sign up | Sign up |
| Facebook Followers | 24,433 | Sign up | Sign up | Sign up |
| Instagram Followers | 19,846 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 942 | Sign up | Sign up | Sign up |
| Twitter Followers | 25,173 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,640 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 67 | Sign up | Sign up | Sign up |
| Linkedin Employees | 10,290 | Sign up | Sign up | Sign up |
About Henry Schein
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services.
| Price | $62.03 |
| Target Price | Sign up |
| Volume | 1,450,000 |
| Market Cap | $7.67B |
| Year Range | $62.03 - $79 |
| Dividend Yield | 0% |
| PE Ratio | 20.34 |
| Analyst Rating | 45% buy |
| Industry | Health Care Services |
In the news
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.October 16 - GlobeNewswire |
|
 |
3 Reasons to Avoid HSIC and 1 Stock to Buy InsteadOctober 7 - Yahoo |
 |
State of Alaska Department of Revenue Has $999,000 Stock Holdings in Henry Schein, Inc. $HSICOctober 6 - ETF Daily News |
 |
Henry Schein (NASDAQ:HSIC) Upgraded at Wall Street ZenOctober 5 - ETF Daily News |
|
Henry Schein, Inc. $HSIC Shares Purchased by V Square Quantitative Management LLCOctober 2 - ETF Daily News |
|
Public Employees Retirement System of Ohio Has $2.67 Million Holdings in Henry Schein, Inc. $HSICOctober 2 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 3.24B | 2.29B | 952M | 86M | 235M | 1.100 |
| Q1 '25 | 3.17B | 2.17B | 1B | 110M | 253M | 1.150 |
| Q4 '24 | 3.19B | 2.2B | 993M | 94M | 237M | 1.190 |
| Q3 '24 | 3.17B | 2.18B | 993M | 99M | 236M | 1.220 |
| Q2 '24 | 3.14B | 2.18B | 955M | 104M | 252M | 1.230 |
Insider Transactions View All
| DANIEL WILLIAM K filed to buy 10,000 shares at $67.1. August 11 '25 |
| Connett Bradford C filed to sell 62,688 shares at $71.2. March 20 '25 |
| LASKAWY PHILIP A filed to sell 24,805 shares at $71. March 20 '25 |
| KUEHN KURT P filed to sell 15,687 shares at $71.5. March 6 '25 |
| Ettinger Michael S filed to sell 87,706 shares at $75. November 20 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Abbott LaboratoriesABT |
$127.63 0% | 44 |
 |
HCA HealthcareHCA |
$419.6 0% | 46 |
 |
Cardinal HealthCAH |
$153.27 0% | 58 |
 |
Idexx LaboratoriesIDXX |
$637.34 0% | 54 |
 |
LabCorpLH |
$283.71 0% | 50 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
May 15, 25 | Sell | $1K - $15K |
| Rob Bresnahan |
May 8, 25 | Buy | $1K - $15K |
| Gil Cisneros |
Apr 8, 25 | Sell | $1K - $15K |
Read more about Henry Schein (HSIC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Henry Schein?
The Market Cap of Henry Schein is $7.67B.
What is Henry Schein's PE Ratio?
As of today, Henry Schein's PE (Price to Earnings) ratio is 20.34.
What is the current stock price of Henry Schein?
Currently, the price of one share of Henry Schein stock is $62.03.
How can I analyze the HSIC stock price chart for investment decisions?
The HSIC stock price chart above provides a comprehensive visual representation of Henry Schein's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Henry Schein shares. Our platform offers an up-to-date HSIC stock price chart, along with technical data analysis and alternative data insights.
Does HSIC offer dividends to its shareholders?
As of our latest update, Henry Schein (HSIC) does not offer dividends to its shareholders. Investors interested in Henry Schein should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Henry Schein?
Some of the similar stocks of Henry Schein are Abbott Laboratories, HCA Healthcare, Cardinal Health, Idexx Laboratories, and LabCorp.
.
